Breaking News

Colgate's Third Quarter Profit Falls

October 25, 2004

Colgate-Palmolive announced financial results for the third quarter. Profit fell due to increasedmarketing spending and higher costs for raw materials. The company earned $329 million, downfrom $365.4 million a year earlier.

Last month Colgate issued its first formal earnings warning in almost a decade, citing highercosts as part of the cause.

For the third quarter, net sales rose to $2.7 billion, compared to $2.5 billion a year ago, in linewith analysts' expectations. Sales and volume each rose 8.5%, excluding divestments, with therecent acquisition of Swiss toothpaste GABA adding 2%, according to executives. Chairman andchief executive Reuben Mark said in a statement that sales growth is excellent but has come at acost to short-term profits.

Colgate maintains its fourth-quarter earnings forecast of $0.57-0.59 cents a share. The companystood by its fourth-quarter earnings forecast of 57 cents to 59 cents per share. This target was givenin September.
  • Sparkle & Shine

    Sparkle & Shine

    Melissa Meisel, Associate Editor||November 21, 2016
    Glam packaging and upscale scent combos are big at Yankee Candle for Holiday 2016.

  • Cos Bar: Turning 40 and Hitting Fast Forward

    Cos Bar: Turning 40 and Hitting Fast Forward

    Christine Esposito, Associate Editor||November 21, 2016
    With a recent investor infusion, a new CEO and rebranding effort underway, this luxury beauty retailer has big plans.

  • Organic Matter

    Organic Matter

    Christine Esposito, Associate Editor||November 14, 2016
    FTC and USDA hold a public roundtable to discuss consumers’ perception of organic claims.

  • The World Comes to Orlando

    The World Comes to Orlando

    Tom Branna , Editorial Director||December 1, 2016
    More than 1,600 chemists traveled to Florida for the IFSCC Congress

  • The Plex  Phenomenon

    The Plex Phenomenon

    Denise Costrini, Croda North America||December 1, 2016
    Croda details the hair-protecting qualities of bond multipliers and the company’s new bond-building formulation system.